文献速递区域麻醉与超声疼痛医学

地塞米松联合右美托咪定作为腘窝及隐神经阻滞辅助剂:随机盲法安慰剂对照试验

Combined Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Surgery of the Foot or Ankle: A Randomized, Blinded, Placebo-controlled Clinical Trial.
PubMed 文献 · Anesthesiology · 2024-01-01

这项随机、盲法、安慰剂对照试验纳入120例在全身麻醉下接受足踝手术并联合腘窝(坐骨)和隐神经阻滞的患者,比较12 mg地塞米松联合1 µg/kg右美托咪定、单用12 mg地塞米松或安慰剂对镇痛持续时间的影响。结果显示,联合组和地塞米松组的中位镇痛持续时间均长于安慰剂组,差异超过预设的33%临床相关阈值,但联合组与单用地塞米松组之间无显著差异。

要点

  • 地塞米松联合右美托咪定或单用地塞米松均延长足踝手术后腘窝和隐神经阻滞的镇痛持续时间。
  • 联合右美托咪定并未比单用地塞米松进一步延长镇痛持续时间。
  • 与安慰剂相比,联合组和地塞米松组的镇痛延长均超过预设的33%临床相关差异。

核心结论

  • 地塞米松联合或不联合右美托咪定均延长足踝手术患者腘窝(坐骨)和隐神经阻滞的镇痛持续时间。
  • 联合右美托咪定与单用地塞米松相比未延长镇痛持续时间。

研究设计与样本

  • 随机、盲法、安慰剂对照临床试验,来自两个中心,共随机分配120例患者,其中119例纳入主要结局分析。
  • 患者接受全身麻醉下足踝手术,并联合腘窝(坐骨)和隐神经阻滞。
  • 干预分为三组:12 mg地塞米松联合1 µg/kg右美托咪定、12 mg地塞米松、安慰剂(生理盐水)。
  • 主要结局为镇痛持续时间,定义为从阻滞操作到患者首次报告手术区域疼痛感觉的时间。
  • 预设33%的镇痛持续时间差异为临床相关差异。

主要发现

  • 中位[四分位距]镇痛持续时间:联合组1572分钟[1259至1715],地塞米松组1400分钟[1133至1750],安慰剂组870分钟[748至1138]。
  • 与安慰剂相比,联合组镇痛持续时间更长(差异564分钟;98.33% CI,301至794;P < 0.001)。
  • 与安慰剂相比,地塞米松组镇痛持续时间更长(差异489分钟;98.33% CI,265至706;P < 0.001)。
  • 联合组与地塞米松组镇痛持续时间相似(差异61分钟;98.33% CI,-222至331;P = 0.614)。

临床怎么用

  • 对于接受足踝手术并实施腘窝和隐神经阻滞的患者,可考虑使用地塞米松(联合或不联合右美托咪定)作为辅助剂以延长镇痛持续时间。
  • 联合右美托咪定未显示比单用地塞米松更优的镇痛延长效果,因此单用地塞米松可能是更简便的选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both dexamethasone and dexmedetomidine increase the duration of analgesia of peripheral nerve blocks. The authors hypothesized that combined intravenous dexamethasone and intravenous dexmedetomidine would result in a greater duration of analgesia when compared with intravenous dexamethasone alone and placebo. METHODS: The authors randomly allocated participants undergoing surgery of the foot or ankle under general anesthesia and with a combined popliteal (sciatic) and saphenous nerve block to a combination of 12 mg dexamethasone and 1 µg/kg dexmedetomidine, 12 mg dexamethasone, or placebo (saline). The primary outcome was the duration of analgesia measured as the time from block performance until the first sensation of pain in the surgical area as reported by the participant. The authors predefined a 33% difference in the duration of analgesia as clinically relevant. RESULTS: A total of 120 participants from two centers were randomized and 119 analyzed for the primary outcome. The median [interquartile range] duration of analgesia was 1,572 min [1,259 to 1,715] with combined dexamethasone and dexmedetomidine, 1,400 min [1,133 to 1,750] with dexamethasone alone, and 870 min [748 to 1,138] with placebo. Compared with placebo, the duration was greater with combined dexamethasone and dexmedetomidine (difference, 564 min; 98.33% CI, 301 to 794; P < 0.001) and with dexamethasone (difference, 489 min; 98.33% CI, 265 to 706; P < 0.001). The prolongations exceeded the authors' predefined clinically relevant difference. The duration was similar when combined dexamethasone and dexmedetomidine was compared with dexamethasone alone (difference, 61 min; 98.33% CI, -222 to 331; P = 0.614). CONCLUSIONS: Dexamethasone with or without dexmedetomidine increased the duration of analgesia in patients undergoing surgery of the foot or ankle with a popliteal (sciatic) and saphenous nerve block. Combined dexamethasone and dexmedetomidine did not increase the duration of analgesia when compared with dexamethasone.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Maagaard M, Funder KS, Schou NK, et al. Combined Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Surgery of the Foot or Ankle: A Randomized, Blinded, Placebo-controlled Clinical Trial. Anesthesiology. 2024. PMID: 38489226. doi:10.1097/ALN.0000000000004977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。